
The company will also showcase its CoreNHanced Technology at the upcoming IFT FIRST 2025.

The company will also showcase its CoreNHanced Technology at the upcoming IFT FIRST 2025.

FDA has published its 2025 Human Foods Program Guidance Agenda, highlighting priorities for completion in 2025, including NDIN guidance, and guidance on food colors made from natural sources.

SPINS’ acquisition of Datasembly aims to deliver real-time, store-level pricing and promotional insights for CPG brands and retailers.

The company calls for a broader support for various men’s health priorities across all life stages.

Discover the latest trends and innovations in active nutrition at this exclusive one-day event, featuring expert insights and networking opportunities.

Major food corporations, Kraft Heinz and General Mills, are reformulating products to remove FD&C and certified colors from their portfolios.

Supplement industry journalist Josh Long brings two decades of regulatory experience to his new role at the Natural Products Association.

Innovation in sustained-release caffeine as well as caffeine derivatives is giving the ingredient new life.

With broader consumer demographics adopting nutricosmetics, manufacturers have an opportunity to offer more targeted support to meet diverse needs.

Pet owners are growing more conscious of what is going into their furry friends’ bodies, creating opportunities for functional products that promote pet longevity.

The 2025 GLP-1 Consumer Opportunity Outlook explores how changing nutritional, sensory, and emotional needs are shaping innovation in food and beverage development.

The new line integrates the Jotrol resveratrol delivery platform for absorption of the molecule.

In her new role, Briggs will oversee regulatory strategy, product development, and innovation in various markets.

The ingredient Vertis PB Pea consolidates multiple functions in a meat alternative.

The At-Home DNA Collection Kit from GenoPalate will be available for purchase online at The Vitamin Shoppe website, offering consumers personalized wellness insights.

Kaneka Nutrients has launched a campaign to combat counterfeit ubiquinol products and misleading claims, partnering with laboratories for market surveillance and testing.

FDA reviewed the GRAS dossier for LF+, TurtleTree's animal-free, precision-fermented lactoferrin.

The expansion of the leadership team is anticipated to support the company’s goals of a global movement of evidence-based wellness.

Bioiberica, the producer of Collavant n2, is the first company in the industry to receive the verification.

The first focus of the new partnership will be on joint health and weight management ingredients from the companies.

Here’s what manufacturers need to know about equipping pilot production facilities.

Nutriearth’s natural vitamin D3 source was also recently approved for marketing in Canada.

The low-dose, easy-to-formulate ingredient is a proprietary blend of two bioactives – N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT) – which were discovered by the company’s Forage AI platform.

New plans for the company include a focus on brand-building, digital marketing, e-commerce, and other areas of growth.

The European nutraceutical market is growing rapidly, but the continent is not a monolith when it comes to consumer trends and product innovation. This article is a blue-print for what nutraceutical success looks like in different European countries.

The low-dose plant-based ingredients, Sleeproot and Zenroot, are expected to grow the company’s presence in the expanding European nutraceutical market.

A look at the most popular immune health ingredients, their benefits, and how to best position them.

The expanded flagship facility is expected to increase efficiency and innovation as well as reduce the carbon footprint.

Ingia Bio received the letters for rebaudioside I, D-psicose, and rebaudioside M—sweeteners used in various foods.

GLP-1 receptor agonist drugs present opportunities for dietary supplement manufacturers to meet the unique needs of GLP-1 users.